{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:39:57Z","timestamp":1783575597381,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cancergen.2012.04.002","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T10:15:26Z","timestamp":1338977726000},"page":"242-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico"],"prefix":"10.1016","volume":"205","author":[{"given":"Julie","family":"Dutil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Colon-Colon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime L.","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sutphen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Echenique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2012.04.002_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2796.2001.00822.x","article-title":"Diet and breast cancer","volume":"249","author":"Willett","year":"2001","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cancergen.2012.04.002_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1582-4934.2005.tb00350.x","article-title":"Understanding breast cancer risk \u2014 where do we stand in 2005?","volume":"9","author":"Dumitrescu","year":"2005","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.cancergen.2012.04.002_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1023959818513","article-title":"Nutrition and lifestyle factors on the risk of developing breast cancer","volume":"79","author":"Gerber","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2012.04.002_bib4","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.04.002_bib5","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.04.002_bib6","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers","volume":"343","author":"Ford","year":"1994","journal-title":"The Lancet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2012.04.002_bib10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium","volume":"91","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.04.002_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","article-title":"Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer","volume":"91","author":"Peto","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.04.002_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1634\/theoncologist.9-1-13","article-title":"Recognition and management of hereditary breast cancer syndromes","volume":"9","author":"Thull","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.cancergen.2012.04.002_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/gte.2005.9.167","article-title":"Does genetic counseling have any impact on management of breast cancer risk?","volume":"9","author":"Watson","year":"2005","journal-title":"Genet Test"},{"key":"10.1016\/j.cancergen.2012.04.002_bib14","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","article-title":"Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1\/2 mutations: an updated decision analysis","volume":"20","author":"Grann","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2004.04.086","article-title":"Impact of BRCA1\/BRCA2 counseling and testing on newly diagnosed breast cancer patients","volume":"22","author":"Schwartz","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archsurg.138.12.1323","article-title":"Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis","volume":"138","author":"Weitzel","year":"2003","journal-title":"Arch Surg"},{"key":"10.1016\/j.cancergen.2012.04.002_bib17","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2003.03.189","article-title":"American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility","volume":"21","author":"American Society of Clinical Oncology","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib18","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice\u00a0guidelines in oncology: genetic\/familial high risk assessment: breast and ovarian.\u00a02011. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#detection. Accessed December 10, 2011."},{"key":"10.1016\/j.cancergen.2012.04.002_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7326\/0003-4819-143-5-200509060-00011","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement","volume":"143","author":"U.S. Preventive Services Task Force","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cancergen.2012.04.002_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/B:JOGC.0000018821.48330.77","article-title":"Genetic cancer risk assessment and counseling: recommendations of the National Society of Genetic Counselors","volume":"13","author":"Trepanier","year":"2004","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.cancergen.2012.04.002_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10897-007-9090-7","article-title":"Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors","volume":"16","author":"Berliner","year":"2007","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.cancergen.2012.04.002_bib22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib24","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","article-title":"BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes","volume":"20","author":"Berry","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib25","author":"Cohn"},{"key":"10.1016\/j.cancergen.2012.04.002_bib26","first-page":"43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cancergen.2012.04.002_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cncr.20288","article-title":"Annual report to the nation on the status of cancer, 1975\u20132001, with a special feature regarding survival","volume":"101","author":"Jemal","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.04.002_bib28","first-page":"342","article-title":"Trends in breast cancer by race and ethnicity","volume":"53","author":"Ghafoor","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cancergen.2012.04.002_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.163.1.49","article-title":"Differences in breast cancer stage, treatment, and survival by race and ethnicity","volume":"163","author":"Li","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cancergen.2012.04.002_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/aje\/155.6.534","article-title":"Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and Size for breast cancer in US women","volume":"155","author":"Miller","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib31","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2105\/AJPH.2005.072132","article-title":"The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis","volume":"96","author":"Lantz","year":"2006","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cancergen.2012.04.002_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajpa.20108","article-title":"Reconstructing the population history of Puerto Rico by means of mtDNA phylogeographic analysis","volume":"128","author":"Mart\u00ednez-Cruzado","year":"2005","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib33","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1200\/JCO.2006.10.4703","article-title":"BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model","volume":"25","author":"Vogel","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib34","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/1055-9965.EPI-05-0072","article-title":"Prevalence of BRCA mutations and founder effect in high-risk Hispanic families","volume":"14","author":"Weitzel","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cancergen.2012.04.002_bib35","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","article-title":"Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial\/ethnic groups","volume":"298","author":"John","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2012.04.002_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y","article-title":"The breast cancer information core: database design, structure, and scope","volume":"16","author":"Szabo","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2012.04.002_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-005-9047-1","article-title":"Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast\/ovarian cancer, genotype-phenotype correlations","volume":"95","author":"Gallardo","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2012.04.002_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2","volume":"14","author":"Roa","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng0596-126","article-title":"Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer","volume":"13","author":"Neuhausen","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib40","first-page":"505","article-title":"The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women","volume":"60","author":"Abeliovich","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1095-198","article-title":"The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals","volume":"11","author":"Struewing","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng0596-117","article-title":"A\u00a0single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes","volume":"13","author":"Thorlacius","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib43","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.ejca.2004.09.008","article-title":"BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study","volume":"40","author":"Rafnar","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cancergen.2012.04.002_bib44","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1002\/humu.1380110163","article-title":"Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: screening reveals low frequency in Icelandic breast cancer patients","volume":"11","author":"Bergthorsson","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2012.04.002_bib45","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1086\/302922","article-title":"Founder Mutations in the BRCA1 gene in Polish families with breast-ovarian cancer","volume":"66","author":"Gorski","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1086\/318211","article-title":"Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer","volume":"68","author":"de los Rios","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ijc.20406","article-title":"Significant proportion of breast and\/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations","volume":"112","author":"Oros","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2012.04.002_bib48","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/302099","article-title":"Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families","volume":"63","author":"Tonin","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib49","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ng1295-428","article-title":"Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation","volume":"11","author":"Gayther","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib50","first-page":"1041","article-title":"A\u00a0high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families","volume":"60","author":"Peelen","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng1197-341","article-title":"BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients","volume":"17","author":"Petrij-Bosch","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib52","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/S0959-8049(97)00328-6","article-title":"A\u00a0BRCA1 founder mutation, identified with haplotype analysis, allowing genotype\/phenotype determination and predictive testing","volume":"33","author":"Dorum","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cancergen.2012.04.002_bib53","first-page":"1239","article-title":"Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia","volume":"60","author":"Gayther","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib54","first-page":"441","article-title":"Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden","volume":"53","author":"Johannsson","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergencyto.2005.08.019","article-title":"BRCA1 and BRCA2 mutations in a South American population","volume":"166","author":"Jara","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4067\/S0716-97602004000300011","article-title":"Molecular analysis of the eighteen most frequent mutations in the BRCA1 gene in 63 Chilean breast cancer families","volume":"37","author":"Jara","year":"2004","journal-title":"Biol Res"},{"key":"10.1016\/j.cancergen.2012.04.002_bib57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10549-006-9370-1","article-title":"High proportion of BRCA1\/2 founder mutations in Hispanic breast\/ovarian cancer families from Colombia","volume":"103","author":"Torres","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2012.04.002_bib58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/humu.9084","article-title":"BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico","volume":"20","author":"Ruiz-Flores","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2012.04.002_bib59","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ijc.1627","article-title":"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: implications for genetic testing","volume":"97","author":"de la Hoya","year":"2002","journal-title":"Inter J Cancer"},{"key":"10.1016\/j.cancergen.2012.04.002_bib60","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/cncr.11533","article-title":"Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado","volume":"98","author":"Mullineaux","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.04.002_bib61","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/humu.10260","article-title":"Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects","volume":"22","author":"D\u00edez","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2012.04.002_bib62","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/(SICI)1098-1004(200004)15:4<381::AID-HUMU14>3.0.CO;2-H","article-title":"Frequency of germ-line BRCA1 mutations among Spanish families from a Mediterranean area","volume":"15","author":"Blesa","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2012.04.002_bib63","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2105\/AJPH.2005.068668","article-title":"Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research","volume":"95","author":"Gonzalez Burchard","year":"2005","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cancergen.2012.04.002_bib64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/gepi.20079","article-title":"Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics","volume":"29","author":"Salari","year":"2005","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib65","doi-asserted-by":"crossref","first-page":"e16513","DOI":"10.1371\/journal.pone.0016513","article-title":"History shaped the geographic distribution of genomic admixture on the island of Puerto Rico","volume":"6","author":"Via","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cancergen.2012.04.002_bib66","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.294.15.1925","article-title":"Genetic testing in an ethnically diverse cohort of high-risk women","volume":"294","author":"Nanda","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2012.04.002_bib67","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1200\/JCO.2008.16.8310","article-title":"Performance of BRCA1\/2 mutation prediction models in Asian Americans","volume":"26","author":"Kurian","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.04.002_bib68","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1158\/1055-9965.EPI-08-1090","article-title":"Performance of prediction models for BRCA mutation carriage in three racial\/ethnic groups: findings from the Northern California Breast Cancer Family Registry","volume":"18","author":"Kurian","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cancergen.2012.04.002_bib69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMcp071286","article-title":"Management of an inherited predisposition to breast cancer","volume":"357","author":"Robson","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2012.04.002_bib70","first-page":"211","article-title":"A\u00a0pilot study of knowledge and interest of genetic counseling and testing for hereditary breast and ovarian cancer syndrome among Puerto Rican women","volume":"2","author":"Vadaparampil","year":"2011","journal-title":"J\u00a0Community Genet"},{"key":"10.1016\/j.cancergen.2012.04.002_bib71","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/jmg.2004.018234","article-title":"Effects of a cancer genetics education program on clinician knowledge and practice","volume":"41","author":"Blazer","year":"2004","journal-title":"J\u00a0Med Genet"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:04Z","timestamp":1761896284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S2210776212001056"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.04.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}